News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Boehringer Ingelheim Corporation Unit Taps Bank of America (BAC) To Explore Sale Of Generics Business


12/5/2013 8:25:53 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Ben Venue Laboratories, a Bedford, Ohio-based subsidiary of German drugmaker Boehringer Ingelheim has tapped Bank of America Merrill Lynch to explore a possible sale of its generic sterile injectable drugs business. Ben Venue announced in October that it was ceasing production due to quality control issues and said it was "exploring strategic options" for its Bedford Laboratories business. The firm has hired Bank of America "to educate potential buyers about the Bedford Laboratories business" and the Ben Venue manufacturing site, a Boehringer spokeswoman wrote in an email on Tuesday.

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters

comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES